Journal
EMBO JOURNAL
Volume 24, Issue 8, Pages 1571-1583Publisher
WILEY
DOI: 10.1038/sj.emboj.7600633
Keywords
exercise; glucose transport; GSK3 inhibitor AR-A014418; PI 3-kinase; PKB/Akt
Categories
Funding
- MRC [MC_U127070193] Funding Source: UKRI
- Medical Research Council [MC_U127070193] Funding Source: Medline
Ask authors/readers for more resources
The inactivation of glycogen synthase kinase (GSK) 3 has been proposed to play important roles in insulin and Wnt signalling. To define the role that inactivation of GSK3 plays, we generated homozygous knockin mice in which the protein kinase B phosphorylation sites on GSK3 alpha (Ser21) and GSK3 beta (Ser9) were changed to Ala. The knockin mice were viable and were not diabetic. Using these mice we show that inactivation of GSK3 beta rather than GSK3 alpha is the major route by which insulin activates muscle glycogen synthase. In contrast, we demonstrate that the activation of muscle glycogen synthase by contraction, the stimulation of muscle glucose uptake by insulin, or the activation of hepatic glycogen synthase by glucose do not require GSK3 phosphorylation on Ser21/Ser9. GSK3 also becomes inhibited in the Wnt-signalling pathway, by a poorly defined mechanism. In GSK3 alpha/GSK3 beta homozygous knockin cells, Wnt3a induces normal inactivation of GSK3, as judged by the stabilisation of beta-catenin and stimulation of Wnt-dependent transcription. These results establish the function of Ser21/Ser9 phosphorylation in several processes in which GSK3 inactivation has previously been implicated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available